Probing The Binding Mechanism Of Novel Dual NF-κB/AP-1 Inhibitors By 3D-QSAR, Docking And Molecular Dynamics Simulations

Potent dual NF-κB/AP-1 inhibitors could effectively treat immunoinflammatory diseases. An integrated computational study was carried out to identify the most favourable binding sites, the structural features and the interaction mechanisms.